A Collaborative Palliative and Oncology Care Intervention to Improve Symptoms and Coping During Treatment for Head and Neck Cancer

Fox Chase Cancer Center1 site in 1 country21 target enrollmentNovember 7, 2018

ConditionsCancer of Head and Neck

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cancer of Head and Neck
Sponsor: Fox Chase Cancer Center
Enrollment: 21
Locations: 1
Primary Endpoint: Percentage of patients who comply for acceptability of a collaborative palliative and oncology care intervention for patients with HNC receiving CRT
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The investigators propose to conduct the first pilot trial of a collaborative palliative and oncology care intervention for HNC patients receiving CRT to assess the feasibility and acceptability of the intervention. The intervention will incorporate weekly palliative care visits into standard oncology care targeting coping, mood, and symptom management.

Registry

clinicaltrials.gov

Start Date

November 7, 2018

End Date

November 2022

Last Updated

4 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Fox Chase Cancer Center

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•adult patients (≥18 years) with a diagnosis of HNC for which they are undergoing CRT
•receiving all oncology care at Fox Chase Cancer Center (FCCC)
•able to speak and read in English or with assistance from an interpreter

Exclusion Criteria

•patients with prior history of HNC for which they underwent CRT
•patients with uncontrolled psychiatric disorders (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease which the treating clinician believes prohibits informed consent or participation in the study
•patients enrolled on other supportive care intervention trials

Outcomes

Primary Outcomes

Percentage of patients who comply for acceptability of a collaborative palliative and oncology care intervention for patients with HNC receiving CRT

Time Frame: 12 months

The intervention will be considered feasible if \>50% of patients agree to enroll on the trial and if \> 70% of the participants have at least half of the scheduled palliative care visits